Favipiravir Market Revenue 2024 to 2034
Favipiravir Market Revenue 2024 to 2034
The favipiravir market, at USD 1.2 billion in 2024, is forecasted to reach USD 2.74 billion by 2034, growing at 8.6% CAGR, driven by its adoption as an antiviral therapy and continued infectious disease management.
Report ID: 10495
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 1.20 Bn
Forecast Year,
USD 2.74 Bn
CAGR, 2025 -
8.60%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Favipiravir Market Size Analysis
Favipiravir Market Size By Formulation 2024 to 2034 (USD )
| Formulation | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets | 0.60 | 0.65 | 0.71 | 0.77 | 0.84 | 0.91 | 0.99 | 1.07 | 1.16 | 1.27 | 1.37 |
| Injectables | 0.60 | 0.65 | 0.70 | 0.76 | 0.83 | 0.90 | 0.98 | 1.07 | 1.16 | 1.25 | 1.37 |
Favipiravir Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Influenza | 0.60 | 0.65 | 0.71 | 0.77 | 0.84 | 0.90 | 0.98 | 1.07 | 1.16 | 1.27 | 1.37 |
| Other Viral Infections | 0.60 | 0.65 | 0.71 | 0.77 | 0.83 | 0.91 | 0.98 | 1.06 | 1.17 | 1.26 | 1.37 |
Favipiravir Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.40 | 0.43 | 0.46 | 0.49 | 0.54 | 0.58 | 0.62 | 0.68 | 0.74 | 0.80 | 0.89 |
| Pharmacies | 0.40 | 0.44 | 0.48 | 0.52 | 0.57 | 0.61 | 0.68 | 0.74 | 0.81 | 0.90 | 0.95 |
| Online | 0.40 | 0.44 | 0.47 | 0.52 | 0.57 | 0.62 | 0.67 | 0.72 | 0.77 | 0.82 | 0.89 |
Favipiravir Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.24 | 0.27 | 0.29 | 0.31 | 0.34 | 0.37 | 0.40 | 0.43 | 0.46 | 0.51 | 0.55 |
| Europe | 0.24 | 0.25 | 0.27 | 0.29 | 0.32 | 0.35 | 0.36 | 0.40 | 0.44 | 0.48 | 0.53 |
| Asia Pacific | 0.24 | 0.26 | 0.28 | 0.30 | 0.32 | 0.34 | 0.38 | 0.42 | 0.45 | 0.49 | 0.51 |
| Latin America | 0.24 | 0.26 | 0.29 | 0.31 | 0.34 | 0.37 | 0.39 | 0.43 | 0.46 | 0.51 | 0.57 |
| Middle East & Africa | 0.24 | 0.27 | 0.29 | 0.32 | 0.35 | 0.39 | 0.43 | 0.46 | 0.50 | 0.54 | 0.58 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
